Palo Alto, CA, United States of America

Mei Zhou

This inventor holds 2 USPTO granted patents. Top assignees: Elan Pharmaceuticals, Inc., Neurex Corporation. Active years: 1998-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mei Zhou. Retrieved from https://idiyas.com/inventor/mei-zhou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Mei Zhou

Introduction

Mei Zhou is a notable inventor based in Palo Alto, CA, who has made significant contributions to the field of biotechnology. With a focus on apoptosis and cell survival, he holds 2 patents that reflect his innovative work in this area.

Latest Patents

Among his latest patents is the invention related to the Bax omega protein and methods involving Bax-.omega. polynucleotides and polypeptides. These patents disclose compositions effective to hybridize to Bax-.omega. polynucleotides. Additionally, they outline methods for altering apoptosis in cells, promoting cell survival, and identifying compounds that can affect the binding of Bax-.omega. to other proteins involved in apoptosis.

Career Highlights

Throughout his career, Mei Zhou has worked with prominent companies in the biotechnology sector, including Neurex Corporation and Elan Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise and innovative capabilities in the field.

Collaborations

Mei Zhou has collaborated with several professionals, including Catherine M. Bitler and Stephen S. Bowersox, which has further enriched his research and development efforts.

Conclusion

Mei Zhou's work exemplifies the intersection of innovation and biotechnology, showcasing his commitment to advancing our understanding of apoptosis and cell survival. His contributions continue to impact the field significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…